Infection of COVID‐19 by the body could lead to a massive release of proinflammatory cytokines, resulting in the chronic inflammatory reaction, and decreasing insulin secretion, thereby aggravating the risk of DM [68]. This evidence concerns the gene INS and COVID-19.